Patents/Inventors

Lynn Macdonald

Harrison, NYUS37 patents

34 Patents

US125821052026
Genetically Modified T Cell Receptor Mice
Regeneron Pharmaceuticals, Inc.
0 cites
US125530642026
Methods and Compositions for Targeted Genetic Modification Through Single-step Multiple Targeting
Regeneron Pharmaceuticals, Inc.
0 cites
US125437112026
Non-human Animals Expressing Ph-sensitive Immunoglobulin Sequences
Regeneron Pharmaceuticals, Inc
0 cites
US125437132026
Mice That Make Heavy Chain Antibodies
Regeneron Pharmaceuticals, Inc.
0 cites
US125389052026
Mouse Having a Humanized B-cell Activating Factor Gene
Regeneron Pharmaceuticals, Inc.
0 cites
US124863352025
Mice That Make VL Binding Proteins
Regeneron Pharmaceuticals, Inc.
0 cites
US124417842025
Human Antibodies to Artemin and Methods of Use Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites
US124332642025
Non-human Animals Having an Engineered Immunoglobulin Lambda Light Chain Locus
Regeneron Pharmaceuticals, Inc.
0 cites
US124332652025
Non-human Animals Having a Humanized a Proliferation-inducing Ligand Gene
Regeneron Pharmaceuticals, Inc.
0 cites
US124332662025
Humanized Light Chain Mice
Regeneron Pharmaceuticals, Inc.
0 cites
US124145512025
Genetically Modified Major Histocompatibility Complex Mice
Regeneron Pharmaceuticals, Inc.
0 cites
US123964442025
Mouse Comprising a Humanized TRKB Locus
REGENERON PHARMACEUTICALS, Inc.
0 cites
US123898882025
Mice Expressing a Limited Immunoglobulin Light Chain Repertoire
Regeneron Pharmaceuticals, Inc.
0 cites
US123569672025
Immunoglobulin Lambda Light Chain and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US123428012025
Methods for Producing Antigen-binding Proteins Against Foreign Antigens
Regeneron Pharmaceuticals, Inc.
0 cites
US122953542025
Non-human Animals Expressing Exogenous Terminal Deoxynucleotidyltransferase
Regeneron Pharmaceuticals, Inc.
0 cites
US122076282025
ADAM6 Mice
Regeneron Pharmaceuticals, Inc.
0 cites
US122010962025
Non-human Animals Comprising a Humanized Coagulation Factor 12 Locus
REGENERON PHARMACEUTICALS, Inc.
0 cites
US121148932024
Flexible Drive Tube for Laparoscopic Device
Gyrus ACMI, Inc.
0 cites
US120825662024
Rodent Animals Expressing Human CR1
Regeneron Pharmaceuticals, Inc.
0 cites
US120639152024
Humanized T Cell Co-receptor Mice
Regeneron Pharmaceuticals, Inc.
0 cites
US120589872024
Mouse Having a Humanized B-cell Activating Factor Gene
Regeneron Pharmaceuticals, Inc.
0 cites
US120362882024
Methods of Using Humanized Fcγr Mice to Assay Fc Regions
Regeneron Pharmaceuticals, Inc.
0 cites
US119573832024
Colpotomy Cup Assembly
Gyrus ACMI, Inc.
0 cites
US119505782024
ADAM6 Mice
Regeneron Pharmaceuticals, Inc.
0 cites
US119328592024
Nuclease-mediated DNA Assembly
Regeneron Pharmaceuticals, Inc.
0 cites
US119266612024
Human Antibodies to Artemin and Methods of Use Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites
US117374352023
Non-human Animals Comprising a Humanized Coagulation Factor 12 Locus
Regeneron Pharmaceuticals, Inc.
0 cites
US116978282023
Methods and Compositions for Targeted Genetic Modification Using Paired Guide Rnas
Regeneran Pharmaceuticals, Inc.
0 cites
US116660402023
Humanized Non-human Animals with Restricted Immunoglobulin Heavy Chain Loci
Regeneron Pharmaceuticals, Inc.
0 cites
US116173572023
Humanized Light Chain Mice
Regeneron Pharmaceuticals, Inc.
0 cites
US116121512023
Humanized Light Chain Mice
Regeneron Pharmaceuticals, Inc.
0 cites
US115769842023
Genetically Modified Mouse with Humanized Immunoglobulin Heavy Chain Constant Region Genes and Method of Using
Regeneron Pharmaceuticals, Inc.
0 cites
US115590502023
Humanized Non-human Animals with Restricted Immunoglobulin Heavy Chain Loci
Regeneron Pharmaceuticals, Inc.
0 cites